The Efficacy and Safety of Fostamatinib in Elderly Patients with Immune Thrombocytopenia: A Single-Center, Real-World Case Series

Fostamatinib is a small molecule spleen tyrosine kinase (Syk) inhibitor that was approved for the treatment of adult patients with immune thrombocytopenia (ITP) in second-line therapy. Syk inhibition prevents cytoskeletal rearrangements during phagocytosis, allowing platelet survival in ITP. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jessica, Hsia, Cyrus C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649323/
https://www.ncbi.nlm.nih.gov/pubmed/36393999
http://dx.doi.org/10.1155/2022/8119270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649323/
https://www.ncbi.nlm.nih.gov/pubmed/36393999
http://dx.doi.org/10.1155/2022/8119270

Ejemplares similares